PHF Bridge Grant Call For Applications – Proposal Deadline November 17, 2017
Guidelines and Forms are attached or go to:
Dr. Linda Mason will host a Beginning Grantwriting Workshop for faculty, graduate students,
staff and administrators of Oklahoma higher education institutions on Monday, November 6, from
9 am to 3:30 pm in the OCAP Conference Room, Suite 450 in Building 840 of Research Park in
Oklahoma City. There is no fee for the workshop, but you must register. Send an email with your
contact information and position in higher education to email@example.com. The workshop is limited
to 20 participants. It is helpful to bring a laptop computer for hands-on activities in the workshop.
New Video Provides Overview of New NIH Policies on Human Subjects Research
and Clinical Trials: Do you do research with human participants? If so, you play an important
role in NIH initiatives to improve accountability and transparency in the human subject research.
This overview of New NIH Policies on Human Subjects Research and Clinical Trials provides a
succinct explanation of the various policy changes and what they mean for you.
The Office of Technology Development will offer the Innovation to Impact Series
Session 4 – “Copyright 101 .” Topics to be discussed will be: What is a Copyright?; How do I protect
myself from Copyright Infringement claims?; What is fair use?; and Is there value in Copyright?
This session will occur on October 25th from Noon- 1:00 pm in Biomedical Research Center Building,
Room 103. Lunch will be provided.
Please RSVP to firstname.lastname@example.org by August 24th. Space is limited to the first 15 attendees.
OKC Innovates Symposium: Big Data is Wednesday, October 18, 2017 from 1-5 pm at the
Embassy Suites Downtown/Medical Center. A reception will follow the event from 5-6 pm.
To Register go to: https://www.eventbrite.com/e/okc-innovates-symposium-big-data-tickets-37949343508
For additional information go to: http://www.okcinnovation.com/
Notice of Changes to NIH Policy for Issuing Certificates of Confidentiality
Effective October 1, 2017
(See notice here – https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-109.html)
Effective October 1, 2017, all research that was commenced or ongoing on or after December 13,
2016 and collects or uses identifiable, sensitive information will automatically be issued a Certificate
of Confidentiality (CoC) for applicable NIH awards as part of the award terms and conditions
This policy applies to all biomedical, behavioral, clinical, or other research funded wholly or in part by
NOTE: Studies that have a CoC must include specific language in the informed consent form (if
applicable to the research study). The OUHSC IRBs will evaluate NIH-funded studies on a case-
by-case basis and may request investigators revise their consent forms to add CoC language at the
time of Continuing Review or Modification submissions (see OUHSC Consent Template for language).
Please visit the NIH CoC website for more information: https://humansubjects.nih.gov/coc/index
You can also visit their FAQs page for helpful information pertaining to CoCs.
Additional links and information are also posted under Resources on the IRB website:
Legacy (downloadable PDF) grant application forms are going away December 31!
For NIH you will submit your application using ASSIST. Consider changing now – ASSIST
is very user friendly, and catches most errors before submission.
ORA Noon Conference: Introduction to Grant Writing - This talk is designed to present a
brief overview of the grant writing process and considerations for new investigators or those new to
grant writing. We will also touch upon the 2016 NIH changes to the review process in which reviewers
are asked to search for evidence that an applicant has been responsive to the areas that NIH deems
important to enhancing rigor and reproducibility, the corresponding NIH recommendations for changes
to the format of the research plan, and the three key questions that reviewers are asked to consider
when reviewing grant applications. Thursday, October 26, 2017; Bird Library Auditorium, LIB-299 from
11:30 pm - 1:00 pm
Application and Report Submission Flexibilities Available to Institutions Impacted by Hurricane Maria
Extension of Deadline for Submitting a Response to NOT-CA-17-079, Request for Information on
Bioethics Issues in Cancer Research and Care (NOT-CA-17-094)
The NIH Announces New Review Criteria for Career Development Award Applications Involving
Clinical Trials (NOT-OD-17-121)
The NIH Announces New Review Criteria for Ruth L. Kirschstein National Research Service
Award (NRSA) Individual Fellowship Applications Involving Research Experiences in Clinical
The NIH Announces New Review Criteria for Ruth L. Kirschstein National Research Service
Award (NRSA) Institutional Research Training Grants Involving Research Experiences in Clinical
NIH Operates Under a Continuing Resolution Through December 8, 2017 (NOT-OD-17-124)
NIH Offers Assistance to Active Phase I HHS SBIR and STTR Awardees through the Niche
Assessment Program 2017-2018 (NOT-OD-17-128)
Notice Announcing Applicant Information Webinars for Science of Behavior Change Common
Fund Program Funding Opportunity Announcements (RFA-RM-17-022, RFA-RM-17-023,
RFA-RM-17-024, RFA-RM-17-028) (NOT-RM-17-039)
Notice of Change in Eligibility Requirements for PAR-17-001 "Emerging Global Leader Award
Notice of Limited Competition for Continuation of Regional Medical Center Health Care Provider
Organizations Released (NOT-PM-18-001)
Notice of NCI's Participation on PAR-17-474, Reducing Stigma to Improve HIV/AIDS Prevention,
Treatment, and Care in Low and Middle-Income Countries (R21) (NOT-CA-17-095)
Notice of NIAAA's Participation in PAR-17-070 "Innovative Program to Enhance Research Training
(IPERT) (R25) (NOT-AA-17-012)
Notice of NIAID's Withdrawal from Participation in PAR-15-287 "Opportunities for Collaborative
Research at the NIH Clinical Center (U01)" (NOT-AI-17-045)
Notice of NIAID's Withdrawal from Participation in PAR-15-286 "Pre-Application: Opportunities for
Collaborative Research at the NIH Clinical Center (X02)" (NOT-AI-17-046)
Notice of NINR's Participation in PAR-17-496 "Funding Opportunity Announcement for Intervention
Research to Improve Native American Health (R01)" (NOT-NR-17-026)
Notice of Pre-Application Webinar for RFA-DK-17-014 "Diabetic Foot Consortium - Clinical
Research Units (U01)" (NOT-DK-18-001)
Notice to Extend PAR-15-331 Advanced Development of Informatics Technologies for Cancer
Research and Management (U24) (NOT-CA-17-090)
Notice to Extend PAR-15-332, Early-Stage Development of Informatics Technologies for Cancer
Research and Management (U01) (NOT-CA-17-091)
Notice to Extend PAR-15-333, Sustained Support of Informatics Resources for Cancer Research
and Management (U24) (NOT-CA-17-092)
Notice to Extend PAR-15-334, Development of Innovative Informatics Methods and Algorithms for
Cancer Research and Management (R21) (NOT-CA-17-093)
Request for Information (RFI): Seeking Input from Industry on Enhancing the Data Yield from
Clinical Studies of Peripheral Neuromodulation Devices (NOT-RM-17-015)
Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the
Clinical Study and Use of New and Established Peripheral Neuromodulation Devices (NOT-RM-17-023)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least one month prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed) (RFA-EB-17-003) – Deadline December 20, 2017
BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed) (RFA-EB-17-004) – Deadline December 20, 2017
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 - Clinical Trial Not Allowed) (RFA-NS-18-009) – Deadline December 8, 2017
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01) (RFA-NS-18-010) – Deadline January 19, 2018
Developmental Centers for Interdisciplinary Research in Benign Urology (P20 - Clinical Trials Not Allowed) (RFA-DK-17-033) – Deadline February 28, 2018
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) (PAR-18-303) – Deadline January 5, 2018
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 - Clinical Trial Not Allowed) (PAR-18-402) – Deadline January 5, 2018
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 - Clinical Trial Not Allowed) (PAR-18-403) – Deadline January 5, 2018
Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03) - (Clinical Trial Optional) (RFA-HL-18-025) – Deadline February 15, 2018
National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) (PAR-17-341) – Deadline January 25, 2018
NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required) (PAR-18-304) – Deadline February 5, 2018
Women's HIV/AIDS Cohort Study (WHCS ) (R01) (RFA-HD-18-018) – Deadline December 15, 2017
Susan G. Komen Foundation Central and Western Oklahoma – Small Grants – Deadline March 31, 2018
New Clinical Study Opportunities
Please note this is NOT a solicitation for study subjects
Parexel is looking for Principal Investigators to participate in the following clinical studies.
- Parkinson’s Clinical Study
- Phase 3 clinical study on a e-Device for the subcutaneous self-injection of Certolizumab pegol
- Rheumatologists interested in a SLE study
- COPD study
- 106671 Janssen MDD trial opportunity - Indication: treatment resistant depression (TRD)
Please contact Scott Davis at email@example.com if you would like to receive more information on any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.